Dangerous lung disease: High mortality in COPD More and more people suffer from chronic obstructive pulmonary disease (COPD). However, in
Continue reading »
Asthma-causing fungal toxins in E-cigarette products found
Recording of hazardous substances in E-cigarettes? So-called E-cigarettes are in recent years become increasingly popular. However, there are more and
Continue reading »
ZEB1 throttles therapeutic target, protecting KRAS-mutant lung cancer
A cellular identity switch protects a cancer-promoting genetic pathway from targeted therapy, researchers at The University of Texas MD Anderson
Continue reading »
Children with chronic lung diseases at higher risk of flu hospitalisation
Flu vaccination is provided free for children with chronic illnesses, yet uptake is low prompting UNSW researchers to call for
Continue reading »
Free lung cancer screening program builds valuable relationships with patients
A free, simple screening for lung cancer can save a patient money, while building a healthy relationship for any medical
Continue reading »
Gentle treatment for premature babies with lung diseases
Premature babies who are born before their lungs have finished maturing often suffer from a lack of surfactant – a
Continue reading »
Certain blood pressure drugs linked to increased risk of lung cancer
Use of angiotensin converting enzyme inhibitor drugs (ACEIs) to lower blood pressure is associated with an increased risk of lung
Continue reading »
Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection of stage IIIA-N2 stage non-small cell
Continue reading »
Researchers discover aggressive prostate and lung cancers are driven by common mechanisms
UCLA researchers have discovered a common process in the development of late-stage, small cell cancers of the prostate and lung.
Continue reading »
Small reduction in lung function with Tx de-escalation in COPD
(HealthDay)—A de-escalation from triple therapy to indacaterol/glycopyrronium may lead to a small reduction in lung function in non-frequently exacerbating patients
Continue reading »